Biocept announces one-for-thirty reverse stock split

San diego--(business wire)--biocept, inc. (nasdaq: bioc), a leading provider of molecular diagnostic assays, products and services, announces that as a result of its 1-for-30 reverse stock split that became effective at 4:05 p.m. eastern time on may 16, 2023, its common stock will begin trading on a split-adjusted basis with the open of the market today, may 17, 2023. biocept's common stock will continue to trade under the existing trading symbol “bioc.” as a result of the reverse stock split,.
BIOC Ratings Summary
BIOC Quant Ranking